Lung cancer imaging and genetics study
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for lung cancer at Wuhan Union Hospital between July 2024 and July 2027.
- You are over 18 years old.
- You have had at least one chest CT scan before starting treatment.
- A tissue biopsy has confirmed your lung cancer diagnosis.
- You do not have another type of cancer besides lung cancer.
- Your medical records and follow-up information are complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at gene-related information from a lung tumor sample and pairs it with special imaging to better understand non-small cell lung cancer. If you have a confirmed diagnosis and the right samples/tests, this may help researchers match patients to the most useful information for planning treatment.
This study uses an AI system that looks at your PET/CT scan images to figure out the exact type and genetic makeup of your non-small cell lung cancer. The goal is to improve how doctors classify and treat your cancer without needing extra invasive tests.
This study looks at whether combining lung images with a blood test (DNA methylation) can help find lung cancer early. It is for people who have a new diagnosis of lung cancer and have not had treatment yet, as well as for people without cancer as a comparison.
This study is for people at high risk of lung cancer—either long-term heavy smokers or those with a close family member who had lung cancer. It uses a low-dose CT scan to look for early signs of lung cancer, and if you smoke, you'll be asked to join a smoking cessation program.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This study looks at genetic (DNA) and molecular (cell-level) information related to lung cancer to better understand the disease. You may be invited if you have a confirmed primary lung cancer diagnosis, or if you are healthy with no cancer.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.